CIBC Asset Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-7,760
Closed -$399K 1077
2018
Q3
$399K Sell
7,760
-720
-8% -$36K ﹤0.01% 767
2018
Q2
$427K Sell
8,480
-910
-10% -$46.1K ﹤0.01% 756
2018
Q1
$480K Buy
9,390
+980
+12% +$52.3K ﹤0.01% 718
2017
Q4
$442K Sell
8,410
-2,540
-23% -$126K ﹤0.01% 730
2017
Q3
$535K Sell
10,950
-3,280
-23% -$156K ﹤0.01% 687
2017
Q2
$688K Sell
14,230
-1,600
-10% -$73.7K ﹤0.01% 645
2017
Q1
$667K Buy
15,830
+2,490
+19% +$103K ﹤0.01% 655
2016
Q4
$563K Sell
13,340
-3,750
-22% -$153K ﹤0.01% 674
2016
Q3
$748K Sell
17,090
-1,110
-6% -$49.7K 0.01% 625
2016
Q2
$793K Sell
18,200
-900
-5% -$38.8K 0.01% 608
2016
Q1
$842K Sell
19,100
-2,900
-13% -$123K 0.01% 596
2015
Q4
$920K Buy
22,000
+60
+0.3% +$2.53K 0.01% 553
2015
Q3
$856K Buy
+21,940
New +$893K 0.01% 561

Other funds holding FMS

CIBC Asset Management's FMS Position: Q4 2018 in Review

CIBC Asset Management sold out of Fresenius Medical Care (FMS) in Q4 2018, closing a stake of 7,760 shares — an estimated $399K sold.

CIBC Asset Management first reported a position in FMS in Q3 2015 and held it in 13 quarters. The position peaked at $920K in Q4 2015. 197 funds tracked by Wall St. Rank hold FMS as of Q4 2018.

  • CIBC Asset Management reported no remaining Fresenius Medical Care position as of Q4 2018 after selling out during the quarter.
  • CIBC Asset Management sold 7,760 Fresenius Medical Care shares in Q4 2018, an estimated $399K.
  • CIBC Asset Management first reported a position in Fresenius Medical Care in Q3 2015 and held it in 13 quarters.
  • CIBC Asset Management's Fresenius Medical Care position peaked at $920K in Q4 2015.
  • 197 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q4 2018.

Based on CIBC Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.